-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Shiyao Group (01093.HK) announced that SYH2056 tablets (this product) developed by the Group are intended to treat depression. A phase I clinical trial (Research Plan No.: SYH2056-001) to evaluate the safety, tolerability and pharmacokinetic characteristics of a single oral administration of this product in Chinese health participants and food effects studies has been officially launched in China.

Zhitongcaijing·09/01/2026 10:17:20
Listen to the news
Zhitong Finance App News, Shiyao Group (01093.HK) announced that SYH2056 tablets (this product) developed by the Group are intended to treat depression. A phase I clinical trial (Research Plan No.: SYH2056-001) to evaluate the safety, tolerability and pharmacokinetic characteristics of a single oral administration of this product in Chinese health participants and food effects studies has been officially launched in China.